IL235795B - nano46 genes and methods for predicting breast cancer outcome - Google Patents
nano46 genes and methods for predicting breast cancer outcomeInfo
- Publication number
- IL235795B IL235795B IL235795A IL23579514A IL235795B IL 235795 B IL235795 B IL 235795B IL 235795 A IL235795 A IL 235795A IL 23579514 A IL23579514 A IL 23579514A IL 235795 B IL235795 B IL 235795B
- Authority
- IL
- Israel
- Prior art keywords
- methods
- breast cancer
- cancer outcome
- predict breast
- nano46
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title 1
- 208000026310 Breast neoplasm Diseases 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261650209P | 2012-05-22 | 2012-05-22 | |
| US201361753673P | 2013-01-17 | 2013-01-17 | |
| PCT/US2013/042157 WO2013177245A2 (en) | 2012-05-22 | 2013-05-22 | Nano46 genes and methods to predict breast cancer outcome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL235795A0 IL235795A0 (en) | 2015-01-29 |
| IL235795B true IL235795B (en) | 2020-02-27 |
Family
ID=49624503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL235795A IL235795B (en) | 2012-05-22 | 2014-11-20 | nano46 genes and methods for predicting breast cancer outcome |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20130337444A1 (enExample) |
| EP (1) | EP2852689B1 (enExample) |
| JP (1) | JP6325530B2 (enExample) |
| CN (2) | CN111500718A (enExample) |
| AU (1) | AU2013266419B2 (enExample) |
| BR (1) | BR112014029300A2 (enExample) |
| CA (1) | CA2874492C (enExample) |
| ES (1) | ES2763931T3 (enExample) |
| IL (1) | IL235795B (enExample) |
| IN (1) | IN2014MN02418A (enExample) |
| MX (1) | MX369628B (enExample) |
| WO (1) | WO2013177245A2 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2297359T4 (pl) | 2008-05-30 | 2014-07-31 | Univ North Carolina Chapel Hill | Profile ekspresji genów do przewidywania skutków raka piersi |
| AU2012229123B2 (en) | 2011-03-15 | 2017-02-02 | British Columbia Cancer Agency Branch | Methods of treating breast cancer with anthracycline therapy |
| GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
| EP2785873A4 (en) | 2011-11-30 | 2015-11-11 | Univ North Carolina | METHOD FOR THE TREATMENT OF BREAST CANCER WITH TAXAN THERAPY |
| DK3511423T4 (da) | 2012-10-17 | 2024-07-29 | Spatial Transcriptomics Ab | Fremgangsmåder og produkt til optimering af lokaliseret eller rumlig detektion af genekspression i en vævsprøve |
| US20160115551A1 (en) * | 2013-05-13 | 2016-04-28 | Nanostring Technologies, Inc. | Methods to predict risk of recurrence in node-positive early breast cancer |
| EP4234716A3 (en) | 2013-06-25 | 2023-12-06 | Prognosys Biosciences, Inc. | Methods for determining spatial patterns of biological targets in a sample |
| AU2014317843A1 (en) * | 2013-09-09 | 2016-03-24 | British Columbia Cancer Agency Branch | Methods and kits for predicting outcome and methods and kits for treating breast cancer with radiation therapy |
| CN113403373B (zh) | 2014-11-21 | 2025-04-11 | 布鲁克空间生物学公司 | 无酶且无扩增的测序 |
| SG11201704177SA (en) | 2014-11-24 | 2017-06-29 | Nanostring Technologies Inc | Methods and apparatuses for gene purification and imaging |
| JP2018500895A (ja) * | 2014-12-09 | 2018-01-18 | キングス・カレッジ・ロンドン | タキサン療法による乳癌治療 |
| EP4119677B1 (en) | 2015-04-10 | 2023-06-28 | Spatial Transcriptomics AB | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
| US20180209981A1 (en) * | 2015-07-23 | 2018-07-26 | National University Of Singapore | Wbp2 as a co-prognostic factor with her2 for stratification of patients for treatment |
| CN109715825B (zh) | 2016-05-16 | 2023-01-06 | 纳米线科技公司 | 用于检测样品中目标核酸的方法 |
| WO2017222453A1 (en) | 2016-06-21 | 2017-12-28 | Hauling Thomas | Nucleic acid sequencing |
| WO2018074865A2 (ko) * | 2016-10-21 | 2018-04-26 | 서울대학교병원 | 유방암 예후 예측용 조성물 및 방법 |
| JP6730525B2 (ja) | 2016-11-21 | 2020-07-29 | ナノストリング テクノロジーズ，インコーポレイティド | 化学組成物とそれを利用する方法 |
| KR101950717B1 (ko) * | 2016-11-23 | 2019-02-21 | 주식회사 젠큐릭스 | 유방암 환자의 화학치료 유용성 예측 방법 |
| WO2018144782A1 (en) * | 2017-02-01 | 2018-08-09 | The Translational Genomics Research Institute | Methods of detecting somatic and germline variants in impure tumors |
| CN120210336A (zh) | 2017-10-06 | 2025-06-27 | 10X基因组学有限公司 | Rna模板化连接 |
| KR102071491B1 (ko) * | 2017-11-10 | 2020-01-30 | 주식회사 디시젠 | 차세대 염기서열분석을 이용한 기계학습 기반 유방암 예후 예측 방법 및 예측 시스템 |
| EP3794146B1 (en) | 2018-05-14 | 2025-12-10 | Bruker Spatial Biology, Inc. | Method for identifying a predetermined nucleotide sequence |
| WO2020094399A1 (en) * | 2018-11-05 | 2020-05-14 | Biontech Diagnostics Gmbh | Predictive methods in breast cancer |
| CN113906147B (zh) | 2019-05-31 | 2024-09-13 | 10X基因组学有限公司 | 检测目标核酸分子的方法 |
| JP7352937B2 (ja) * | 2019-07-19 | 2023-09-29 | 公立大学法人福島県立医科大学 | 乳癌のサブタイプを鑑別又は分類するための鑑別マーカー遺伝子セット、方法およびキット |
| GB201919032D0 (en) | 2019-12-20 | 2020-02-05 | Cartana Ab | Method of detecting an analyte |
| JP2023514749A (ja) | 2020-02-21 | 2023-04-07 | １０エックス ジェノミクス インコーポレイテッド | 統合型インサイチュ空間的アッセイのための方法および組成物 |
| US12209273B2 (en) | 2020-06-12 | 2025-01-28 | 10X Genomics, Inc. | Nucleic acid assays using click chemistry bioconjugation |
| EP3945136A1 (en) * | 2020-07-28 | 2022-02-02 | Hospital Clínic de Barcelona | In vitro method for the prognosis of patients suffering from her2-positive breast cancer |
| US12297499B2 (en) | 2020-08-17 | 2025-05-13 | 10X Genomics, Inc. | Multicomponent nucleic acid probes for sample analysis |
| US12060603B2 (en) | 2021-01-19 | 2024-08-13 | 10X Genomics, Inc. | Methods for internally controlled in situ assays using padlock probes |
| CA3248919A1 (en) * | 2021-12-20 | 2023-06-29 | Fundacio De Recerca Clinic Barcelona Inst D’Investigacions Biomediques August Pi I Sunyer | DEVELOPMENT AND VALIDATION OF AN IN VITRO PROGNOSIS FOR PATIENTS WITH HER2-POSITIVE BREAST CANCER |
| CN117965734B (zh) * | 2024-02-02 | 2024-09-24 | 奥明星程(杭州)生物科技有限公司 | 一种用于检测硬纤维瘤的基因标志物、试剂盒、检测方法及应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| CA2118806A1 (en) | 1991-09-18 | 1993-04-01 | William J. Dower | Method of synthesizing diverse collections of oligomers |
| AU675054B2 (en) | 1991-11-22 | 1997-01-23 | Affymetrix, Inc. | Combinatorial strategies for polymer synthesis |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
| EP0880598A4 (en) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM |
| DE69829402T2 (de) | 1997-10-31 | 2006-04-13 | Affymetrix, Inc. (a Delaware Corp.), Santa Clara | Expressionsprofile in adulten und fötalen organen |
| US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
| US6750015B2 (en) * | 2000-06-28 | 2004-06-15 | Kathryn B. Horwitz | Progesterone receptor-regulated gene expression and methods related thereto |
| US20020168639A1 (en) * | 2000-09-22 | 2002-11-14 | Muraca Patrick J. | Profile array substrates |
| WO2005039382A2 (en) * | 2003-06-24 | 2005-05-06 | Genomic Health | Prediction of likelihood of cancer recurrence |
| CA2540167A1 (en) * | 2003-09-29 | 2005-05-12 | Pathwork Informatics, Inc. | Systems and methods for detecting biological features |
| WO2006010150A2 (en) | 2004-07-15 | 2006-01-26 | University Of Utah Research Foundation | Housekeeping genes and methods for identifying the same |
| CN101061480A (zh) * | 2004-09-22 | 2007-10-24 | 三路影像公司 | 用来分析和优化用于癌症诊断的标记候选物的方法和计算机程序产品 |
| EP1954708A4 (en) | 2005-11-23 | 2009-05-13 | Univ Utah Res Found | Methods and compositions involving intrinsic genes |
| EP1963531B1 (en) * | 2005-12-23 | 2011-09-21 | Nanostring Technologies, Inc. | Nanoreporters and methods of manufacturing and use thereof |
| JP5700911B2 (ja) | 2005-12-23 | 2015-04-15 | ナノストリング テクノロジーズ，インコーポレーテッド | 配向され、固定化された巨大分子を含む組成物とその製造法 |
| CA2687292C (en) | 2007-04-10 | 2017-07-04 | Nanostring Technologies, Inc. | Methods and computer systems for identifying target-specific sequences for use in nanoreporters |
| WO2008150512A2 (en) * | 2007-06-04 | 2008-12-11 | University Of Louisville Research Foundation, Inc. | Methods for identifying an increased likelihood of recurrence of breast cancer |
| EP2195467B1 (en) * | 2007-09-06 | 2016-12-14 | bioTheranostics, Inc. | Tumor grading and cancer prognosis in breast cancer |
| PL2297359T4 (pl) * | 2008-05-30 | 2014-07-31 | Univ North Carolina Chapel Hill | Profile ekspresji genów do przewidywania skutków raka piersi |
| ES2614810T3 (es) | 2008-08-14 | 2017-06-02 | Nanostring Technologies, Inc | Nanoindicadores estables |
| MX2012011167A (es) * | 2010-03-31 | 2013-02-07 | Sividon Diagnostics Gmbh | Metodo para prediccion de recurrencia de cancer de mama bajo tratamiento endocrino. |
-
2013
- 2013-05-22 IN IN2418MUN2014 patent/IN2014MN02418A/en unknown
- 2013-05-22 CN CN201911216650.9A patent/CN111500718A/zh active Pending
- 2013-05-22 MX MX2014014275A patent/MX369628B/es active IP Right Grant
- 2013-05-22 ES ES13794236T patent/ES2763931T3/es active Active
- 2013-05-22 US US13/899,656 patent/US20130337444A1/en not_active Abandoned
- 2013-05-22 BR BR112014029300A patent/BR112014029300A2/pt not_active Application Discontinuation
- 2013-05-22 EP EP13794236.3A patent/EP2852689B1/en active Active
- 2013-05-22 CN CN201380038875.4A patent/CN104704128A/zh active Pending
- 2013-05-22 AU AU2013266419A patent/AU2013266419B2/en active Active
- 2013-05-22 WO PCT/US2013/042157 patent/WO2013177245A2/en not_active Ceased
- 2013-05-22 CA CA2874492A patent/CA2874492C/en active Active
- 2013-05-22 JP JP2015514143A patent/JP6325530B2/ja active Active
-
2014
- 2014-11-20 IL IL235795A patent/IL235795B/en active IP Right Grant
-
2020
- 2020-02-14 US US16/792,051 patent/US20200332368A1/en not_active Abandoned
-
2022
- 2022-09-29 US US17/936,745 patent/US20230272476A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20230272476A1 (en) | 2023-08-31 |
| JP2015518724A (ja) | 2015-07-06 |
| EP2852689A4 (en) | 2016-05-11 |
| MX2014014275A (es) | 2015-07-06 |
| EP2852689B1 (en) | 2019-12-11 |
| BR112014029300A2 (pt) | 2017-07-25 |
| EP2852689A2 (en) | 2015-04-01 |
| US20200332368A1 (en) | 2020-10-22 |
| MX369628B (es) | 2019-11-14 |
| US20130337444A1 (en) | 2013-12-19 |
| JP6325530B2 (ja) | 2018-05-16 |
| CA2874492A1 (en) | 2013-11-28 |
| AU2013266419A1 (en) | 2014-12-11 |
| IL235795A0 (en) | 2015-01-29 |
| WO2013177245A2 (en) | 2013-11-28 |
| ES2763931T3 (es) | 2020-06-01 |
| CN104704128A (zh) | 2015-06-10 |
| CN111500718A (zh) | 2020-08-07 |
| IN2014MN02418A (enExample) | 2015-08-14 |
| CA2874492C (en) | 2021-10-19 |
| WO2013177245A3 (en) | 2015-01-29 |
| AU2013266419B2 (en) | 2018-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL235795B (en) | nano46 genes and methods for predicting breast cancer outcome | |
| IL288181A (en) | Cancer treatment methods | |
| IL267242B (en) | Cancer treatment | |
| IL236336A0 (en) | Methods of treating breast cancer with gemcitabine therapy | |
| IL237791A0 (en) | A method for treating cancer | |
| EP2760452A4 (en) | METHODS OF TREATING CANCER | |
| SG11201503893RA (en) | Method of treating cancer | |
| PH12014500248A1 (en) | Treatment of breast cancer | |
| EP2895206A4 (en) | METHOD FOR TREATING CARCINOMA | |
| GB2513771B (en) | Biomarkers for breast cancer predictions and diagnoses | |
| EP2638395A4 (en) | METHOD FOR TREATING CARCINOMA | |
| SG11201504300VA (en) | Accelerated prediction of cancer progression and response to treatment | |
| EP2903644A4 (en) | TREATMENT OF CANCER | |
| GB201217892D0 (en) | Treatment of cancer | |
| DK2872176T3 (en) | Cancer treatment | |
| EP2870480A4 (en) | METHOD FOR DETERMINING PERSONALIZED TREATMENT COMPOSITIONS FOR PROSTATE CANCER AND BREAST CANCER | |
| EP2932273A4 (en) | METHOD FOR DIAGNOSIS AND TREATMENT OF PROSTATE CANCER | |
| GB201217890D0 (en) | Treatment of cancer | |
| GB201222563D0 (en) | Cancer treatment | |
| GB201200262D0 (en) | Therapy of breast cancer | |
| GB201222952D0 (en) | Treatent of cancer | |
| GB201202945D0 (en) | Novel cancer therapies and methods | |
| GB201200263D0 (en) | Detection of breast cancer | |
| GB201208296D0 (en) | Treatment of cancer | |
| IL232266A0 (en) | Cancer treatment methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |